Mannkind Successfully Completes Phase 1 Study of Inhaled Clofazimine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/11/2026

1. RPD
2. RKLB
3. ACVA
4. RIOT
5. HIMS
6. NVDA
7. UPWK
8. PLUG
9. SPY
10. WBTN

Go back to Mannkind Successfully Completes Phase 1 Study of Inhaled Clofazimine
Mannkind Corporation (NASDAQ: MNKD) Delayed: 3.93 --0 (-0%)
Previous Close $3.93    52 Week High $2.51 
Open $3.93    52 Week Low $0.41 
Day High $3.93    P/E N/A 
Day Low $3.93    EPS $-0.64 
Volume 5,657       

Mannkind Corporation (NASDAQ: MNKD) Delayed: 3.93 --0 (-0%)
Previous Close $3.93    52 Week High $2.51 
Open $3.93    52 Week Low $0.41 
Day High $3.93    P/E N/A 
Day Low $3.93    EPS $-0.64 
Volume 5,657